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Background: The Siamese crocodile (Crocodylus siamensis) is a critically endangered species of freshwater crocodiles.
Crocodilians live with opportunistic bacterial infection but normally suffer no adverse effects. They are not totally
immune to microbial infection, but their resistance thereto is remarkably effective. In this study, crude and purified
plasma extracted from the Siamese crocodile were examined for antibacterial activity against clinically isolated,
human pathogenic bacterial strains and the related reference strains.
Methods: Crude plasma was prepared from whole blood of the Siamese crocodile by differential sedimentation. The
crude plasma was examined for antibacterial activity by the liquid growth inhibition assay. The scanning electron
microscopy was performed to confirm the effect of crude crocodile plasma on the cells of Salmonella typhi ATCC
11778. Effect of crude crocodile plasma on cell viability was tested by MTT assay. In addition, the plasma was purified
by anion exchange column chromatography with DEAE-Toyopearl 650 M and the purified plasma was tested for
antibacterial activity.
Results: Crude plasma was prepared from whole blood of the Siamese crocodile and exhibited substantial
antibacterial activities of more than 40% growth inhibition against the six reference strains of Staphylococcus aureus,
Salmonella typhi, Escherichia coli, Vibrio cholerae, Pseudomonas aeruginosa, and Staphylococcus epidermidis, and the
four clinical isolates of Staphylococcus epidermidis, Pseudomonas aeruginosa, Salmonella typhi, and Vibrio cholerae.
Especially, more than 80% growth inhibition was found in the reference strains of Salmonella typhi, Vibrio cholerae,
and Staphylococcus epidermidis and in the clinical isolates of Salmonella typhi and Vibrio cholerae. The effect of the
crude plasma on bacterial cells of Salmonella typhi, a certain antibacterial material probably penetrates progressively
into the cytoplasmic space, perturbing and damaging bacterial membranes. The effect of the crude plasma was not
toxic by the yellow tetrazolium bromide (MTT) assay using a macrophage-like cell, RAW 264.7. The pooled four
fractions, designated as fractions D1-D4, were obtained by column chromatography, and only fraction D1 showed
growth inhibition in the reference strains and the clinical, human pathogenic isolates.
Conclusions: The crude and purified plasma from the Siamese crocodile significantly showed antibacterial activity
against pathogenic bacteria and reference strains by damage cell membrane of target bacterial cells. From the MTT
assay, the Siamese crocodile plasma was not cytotoxic to the cells.
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The powerful antibiotic was first discovered in 1940s [1],
many of which originate from natural sources. Mean-
while, microbes resistant to these antibiotics continu-
ously emerge over time and spread all over the world.
This situation motivated scientists to search for new nat-
urally occurring bacterial agents that may be potential
antibiotics. Reptiles including alligators and crocodiles
were subjected to an exploration of the antibiotic proper-
ties from their body.
Bacteria and fungi coexist with other living organisms.
Despite such an ecological phenomenon, pathogenic mi-
crobial invasion into hosts does not normally take place,
as the host has the defense mechanisms that counteract
infection. One of such systems is based on non-specific
immunity, which comprises a wide variety of peptides [2]
and factors [3] with potent antimicrobial properties.
A kind of crocodiles (Crocodylus siamensis), the Siam-
ese crocodile is a critically endangered species of fresh-
water crocodiles, originally distributed in most of South
East Asia. Crocodilians live with opportunistic bacterial
infection but normally suffer no adverse effects. They are
not totally immune to microbial infection, but their re-
sistance thereto is remarkably effective. The immune sys-
tem of crocodilians has not been well characterized, but
there are several reports that describe the antimicrobial
efficacy of alligator serum towards bacteria, viruses, and
amoeba [4-6]. Merchant et al. [5] recently proposed that
the complement systems of alligators are effective in kill-
ing bacteria. More recently, leukocyte extract of the
American alligator (Alligator mississippiensis) showed a
broad spectrum of antibiotic properties on bacteria,
fungi, and viruses [7,8]. Effects of bacterial lipopolysac-
charide on peripheral leukocytes were also investigated
in the American alligator [9].
In the present study, we have examined the crude and
purified plasma obtained from the Siamese crocodile for
the antibacterial activity against clinically isolated, human
pathogenic bacterial strains and the related reference
strains, which will be of great importance in medical
industry.Materials and methods
Plasma samples
Crocodiles (Crocodylus siamensis) were captured and
housed at the local Sriracha Moda Farm, Chon Buri,
Thailand. The crocodiles (age ranging from 1–3 years)
were housed in a single tank, and treated with electric
shock. Blood samples were collected from the dorsal vein
using a heparinized 38 mm long 18 gauge needle and a
60 ml syringe and transferred to heparinized vacuum
tubes. The crocodile blood in heparinized vacuum tubes
was kept at 4°C for overnight and then centrifuged 800 gto obtain crude plasma, which was kept at −70°C until
used [1-3,7,10-16].
Bacterial strains
Staphylococcus aureus ATCC 25923, Salmonella typhi
ATCC 11778, Escherichia coli O157:H7, Vibrio cholerae
non01, Pseudomonas aeruginosa ATCC 27853, Staphylo-
coccus epidermidis ATCC 12228, Staphylococcus epider-
midis clinical isolate 1, Pseudomonas aeruginosa clinical
isolate 1, Salmonella typhi clinical isolate 1, and Vibrio
cholerae clinical isolate 1 were maintained in nutrient
agar slants at 4°C.
Purification of plasma by DEAE
After blood centrifugation for plasma collection, crude
plasma 200 ml was diluted with 18 ml of 25 mM sodium
acetate buffer, pH 5.0 and stirred for 10 min at room
temperature. The homogenate was centrifuged at 12000 g
for 15 min. The supernatant was collected, stirred, and
incubated with CM-Toyopearl 650 M cation exchange
resin. The incubated resin was packed on column and
washed with 2 cv of 25 mM acetate buffer, pH 5.0. The
un-absorbed protein fraction including washings was
adjusted to pH 8.1 and then loaded onto the DEAE-
Toyopearl 650 M anion exchange resin equilibrated with
25 mM Tris–HCl, pH 8.1. The absorbed fraction was
eluted with stepwise NaCl concentration of 0.1, 0.2, 0.3,
0.4, and 0.5 M at flow rate of 1.0 ml/min. The eluted
fraction was collected and monitored at A280 nm for
determining the peak of protein.
Assay of antibacterial activity
The antimicrobial activity of the crude plasma prepar-
ation was evaluated against the four pathogens and six
reference strains. The antibacterial activity was measured
by the disc diffusion method [17] with modifications.
The inoculation of each bacterium was done by placing
inoculum 107 CFU/ml on Mueller-Hinton agar (Scharlau,
Spain). After drying the agar for 3 to 5 min, 6 mm discs
were applied to each plate, and the DEAE eluate fractions
(25 μl; concentration, 1 mg/ml) was pipetted onto each
disc. The agar plates were incubated at 37°C for 18 h.
Clear zone diameter was measured with a ruler at the
back of the plate. Deionized distilled water (DDW) and
streptomycin 10 μg on discs were used respectively as
negative and positive control assays.
The DEAE eluate fractions were assayed for antibac-
terial activity against the ten test strains mentioned
above by a liquid growth inhibition assay [18]. DDW and
streptomycin 3 μg were used respectively as negative and
positive controls. The antimicrobial activity tests were
done in triplicate to obtain valid statistical evaluation
of the results, which were expressed as mean ± S.D.
The percentage of the growth inhibition was calculated
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CI (%) = (A - B)/A × 100, where CI is the percentage
inhibition index, A is the value observed at A550 nm
of bacteria for negative control, and B is the value
observed at A550 nm of bacteria for a plasma eluate or
streptomycin.
Scanning electron microscopy
The scanning electron microscopy (SEM) was performed
according to Lau et al. [19] with slight modifications.
Salmonella typhi ATCC 11778 was grown in nutrient
broth and harvested at the logarithmic phase of growth
by centrifugation at 3,000 g for 5 min. The bacterial cells
were then washed twice with phosphate buffered saline
(PBS), pH 7.0 and re-suspended to the final concentration
of 106 CFU/ml. Aliquots of suspension of Salmonella
typhi ATCC 11778 (100 μl) were individually incubated
with the crude plasma (300 μg/50 μl) at 37°C for 2 h. The
incubated bacterium 150 μl was fixed with equal volumes
of 2.5% glutaraldehyde (Sigma, USA) in 0.1 M phosphate
buffer, pH 7.2 for 2 h. The fixed cells were carefully
pipetted and settled onto a 0.2 μm polycarbonate mem-
brane filter (Whatman, Germany) for five min and then
washed twice with PBS, pH 7.0. The fixed material was
dehydrated by rinsing for 15 min repeatedly with ethanol
solutions, of which the concentration was elevated step-
wise from 30%, 50%, 70%, 90%, and finally 100% ethanol.
The dehydrated material in the absolute ethanol was
dried in a critical point drier (Critical point drier, Balzers
model CPD 020) with carbon dioxide as the drying agent.
The dry material was coated by sputter coater (Sputter
Coater, Balzers model SCD 040) with gold palladium and
examined by a scanning electron microscope (JEOL,
model JSM-5410LV). The negative control was per-
formed in a similar manner except that the bacterial cells
were incubated with PBS, pH 7.0 instead of the crude
crocodile plasma.
Cell line
The mouse macrophage cell line, RAW 264.7 was
obtained from the European Collection of Cell Cultures
(ECACC) and cultured in RPMI medium supplemented
with 10% heat-inactivated fetal bovine serum (FBS),
penicillin 100 units/ml, streptomycin 100 μg/ml, and
amphotericin B 25 μg/ml were maintained at 37°C in
a 5% CO2 humidified atmosphere (CO2 incubator,
Heal Force). The cells were treated with the crude
plasma at different concentrations during 1 h for the
indicated period.
MTT assay for cell viability
Cells were seeded at a density of 104 cells/well in 96-well
plates overnight, followed by the treatment with different
concentrations of the crude plasma, 62.5, 125, 250, 500,and 1,000 μg/ml. The cell viability of RAW 264.7 was
measured after 24 h exposure to the test plasma by col-
orimetric assay, based on the ability of mitochondria in
viable cells to reduce MTT [3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide]. An aliquot of MTT
solution 0.5 mg/ml was added to each well, and after
30 min incubation at 37°C, the medium was discarded,
and the formazan blue formed in the cells was dissolved
in dimethyl sulfoxide (DMSO). Absorbance at 570 nm
was determined with a microplate reader (Bio-Rad, Model
680, USA). The absorbance of the formazan formed in
non-treated cells was taken as 100% viability.
Statistical analysis
Data points in all experiments were performed in tripli-
cate to obtain valid statistical evaluation of the results.
Each sample CFUs/ml was calculated by multiplying the
number of colonies counted by the dilution factor.
All results represented the means ± S.E.M for at three
determinations.
Results
Antibacterial activity of crude crocodile plasma
The undiluted crude Siamese crocodile plasma contain-
ing 114 mg protein/ml determined by the Bradford assay
(Bradford, 1976) was examined for antibacterial activity
by the liquid growth inhibition assay. The crocodile
plasma was effective as an antibacterial substance against
the following six reference strains and four pathogenic
isolates significantly: Staphylococcus aureus ATCC 25923,
Salmonella typhi ATCC 11778, Escherichia coli O157:H7,
Vibrio cholerae non01, Pseudomonas aeruginosa ATCC
27853, Streptococcus epidermidis ATCC 12228, Strepto-
coccus epidermidis clinical isolates 1, Pseudomonas aeru-
ginosa clinical isolate 1, Salmonella typhi clinical isolate 1,
and Vibrio cholerae clinical isolate 1. The inhibition effects
on the bacterial strains were mostly over 40% (Figure 1).
Especially, the crocodile plasma showed high inhibition
effects more than 80% on Salmonella typhi ATCC 11778,
Vibrio cholerae non01, Streptococcus epidermidis ATCC
12228, Pseudomonas aeruginosa clinical isolates 1, and
Salmonella typhi clinical isolates 1. The experimental
data obtained indicated that the crude Siamese crocodile
plasma had antibacterial properties and bactericidal
actions to some bacterial strains both gram-positive and
gram-negative.
Antibacterial action of crocodile plasma examined
by scanning electron microscopy
The effect of the crude crocodile plasma on the cell of Sal-
monella typhi ATCC 11778 tested as a reference strain was
examined by SEM. As shown in Figure 2a, the untreated
cells had smooth, intact cell surfaces. In contrast, crude
plasma-induced breakage and roughness was shown in the
Figure 1 The antibacterial effect of the crude Siamese crocodile
plasma on pathogenic bacteria. The final protein concentration of
the crude plasma examined was 50 μg/ml. 1, Staphylococcus aureus
ATCC 25923; 2, Salmonella typhi ATCC 11778; 3, Esccherichia coli
O157:H7; 4, Vibrio cholerae non01; 5, Pseudomonas aeruginosa ATCC
27853; 6, Streprococcus epidermidis ATCC 12228; 7, Streprococcus
epidermidis clinical isolate 1; 8, Pseudomonas aeruginosa clinical
isolate 1; 9, Salmonella typhi clinical isolate 1; 10, Vibrio cholerae
clinical isolate 1. Bars represent the mean and the standard
deviations performed in triplicate.
Figure 3 The effect of the crude Siamese crocodile plasma on a
macrophage-like cell, RAW 264.7 determined by the MTT assay.
The final protein concentration of the plasma tested was 1000 μg/ml.
The cell viability without crude plasma was taken as 100%, where
n = 8 (mean± S.E.M.).
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results obtained indicated that the cell surface including
bacterial cell walls and/or cell membranes was an import-
ant target for action by the crocodile plasma.Effect of crude crocodile plasma on cell viability
To assess the cytotoxicity of the crocodile plasma admi-
nistered to the cells, macrophages RAW 264.7 was used.
Although the MTT assay is an indirect measurement of
cell density or the number of living cells attached to the
culture plate by formation of colored formazan crystals,
the crocodile plasma exhibited almost similar viability of
more than 96% to that of non-treated cells, which was
taken as 100% viability (Figure 3). The results obtained
indicated that the crocodile plasma was not cytotoxic to
the cells.Figure 2 The antibacterial effect of the crude Siamese crocodile plasm
incubated with the crude plasma for 120 min and observed by scanning eAntibacterial activity of partially purified crocodile plasma
The Siamese crocodile plasma was separated into four
pooled fractions by anion exchange column chromatog-
raphy with DEAE-Toyopearl 650 M, designated as fractions
D1, D2, D3, and D4 (Figure 4). Fractions D1 and D2 were
eluted at 0.1 M NaCl concentration, whereas fractions D3
and D4 were eluted respectively at 0.2 and 0.3 M NaCl. All
the fractions were assayed for antimicrobial activity.
In the disc diffusion assay that was made as a qualita-
tive analysis, some of the four fractions exhibited anti-
bacterial activities against all the tested ten pathogenic
bacteria (Table 1). The most active fractions were found
in fraction D1 in all the ten test strains. The activity of
the other three fractions, D2, D3, and D4 was, however,
calculated to be 50% or less of that of fraction D1.
In the liquid growth inhibition assay that was made
as a quantitative analysis, clear results were obtained
(Figure 5). In only fraction D1, significantly inhibited the
growth of all tested bacteria, which almost corresponded
to that of streptomycin 3 μg/ml. Interesting is that the
growth of both Salmonella typhi ATCC 11778 and clin-
ical isolate 1 and Streptococcus epidermidis ATCC 1222
and clinical isolate 1 was not inhibited by streptomycin.a on cells of Salmonella typhi ATCC 11778. The cells were
lectron microscopy. a, without incubation; b, with incubation.
Figure 4 The DEAE chromatography of the crude Siamese crocodile plasma. The chromatography was made on a DEAE-Toyopearl 650 M
column. Fraction D1 contained fraction tube numbers 19–24, fraction D2 contained fraction tube numbers 27–72, fraction D3 contained fraction
tube numbers 73–96, and fraction D4 contained fraction tube numbers 133–142. ●, absorbance at 280 nm; ■, concentration of NaCl.
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The antibacterial activity has been reported in the
American alligator (Alligator mississippiensis), the salt-
water crocodile (Crocodylus porosus), and the freshwater
crocodile (Crocodylus johnstoni) [5,20]. However, only a
few reports were found in one of the freshwater Siamese
crocodiles [13]. In the present study, the Siamese croco-
dile plasma was effective as an antibacterial agent
against the following six reference strains and the four
pathogens both Gram-negative and Gram-positive spe-
cies: Staphylococcus aureus ATCC 25923, Salmonella
typhi ATCC 11778, Ecsherichia coli. coli O157:H7,Vibrio
cholerae non01, Pseudomonas aeruginosa ATCC 27853,
Streptococcus epidermidis ATCC 12228, Streptococcus
epidermidis clinical isolate 1, Pseudomonas aeruginosa
clinical isolate 1, Salmonella typhi clinical isolate 1, and
Vibrio cholerae clinical isolate 1. All the bacterial species
used in this study are known to be human pathogens. It
is obvious that the Siamese crocodile plasma has a broadTable 1 The antibacterial activity of the DEAE eluate
fractions determined by the disc diffusion assay
Bacterial strain Inhibition zone (mm) of fraction*
D1 D2 D3 D4
S. aureus ATCC 25923 9.6 2.4 2.5 -
S. typhi ATCC 11778 12.4 - - -
E. coli O157:H7 5.5 2.2 2.8 -
V. cholerae non01 10.8 3.1 - -
P. aeruginosa ATCC 27853 6.7 2.5 1.8 -
S. epidermidis ATCC 12228 14.2 1.8 - -
S. epidermidis clinical isolate 1 12.5 2.4 2.5 -
P. aeruginosa clinical isolate 1 6.5 1.8 1.5 -
S. typhi clinical isolate 1 11.8 2.8 2.2 1.3
V. cholerae clinical isolate 1 9.7 2.6 2.0 1.4
For the assay condition, see the text. -, no growth inhibition.
*The values not include diameter of paper disc.band of spectrum in antibacterial activities. The results
demonstrated that the antibacterial activities were highly
effective as an antibacterial agent against both Gram-
positive and Gram-negative bacteria, consistent with the
study in American alligator serum [6].
Antimicrobial peptides have been isolated from a broad
variety of phylogenetically diverse organisms and sepa-
rated into a variety of classes based on their chemical
structures [21]. The classes of the peptides showed differ-
ent kinds of mechanisms on antimicrobial action [13].
In the present study, the antibacterial mechanism of the
crude Siamese crocodile plasma on the cell surface,
including cell walls and membranes, of Salmonella typhi
ATCC 11778, a reference strain was studied by SEM.
The results obtained suggested that an antibacterial com-
pound probably penetrates progressively into the cyto-
plasmic space, perturbing and damaging bacterial cell
surface, as found in the previous report of Preecharram
et al. [13], who isolated an antibacterial compound called
crocosin from the Crocodylus siamensis plasma using
RP-HPLC and found that the compound exhibited an
antibacterial activity toward Salmonella typhi and
Staphylococcus aureus. These results in the actions of the
antimicrobial compounds correspond with the actions of
the antimicrobial peptides such as bactenecin 5, bactene-
cin 7, poly-L-lysine, cecropin B, LL-37 PGYa, melittin,
Hecate-1 and SMAP-29 [11,12,14,22-24]. Most anti-
bacterial peptides found thus far, such as those from
amphibian skin, magaingnin and dermaseptin are known
to exert their antimicrobial activity by permeabilizing the
membrane [11,23]. The antibacterial compound isolated
by Preecharram et al. [13] has a similar mechanism on
action to those of the antibacterial peptides reported
[14,22] in disrupting the cell surface. However, all anti-
microbial peptides have several factors, in common,
which are able to interact with the negatively charged
phospholipids in the membranes of microbes and are
also amphipathic, so that the compounds interact with
Figure 5 The antibacterial activity of the DEAE eluate fractions determined by the liquid growth inhibition assay. The growth inhibition
test was made for 16 h with the final protein concentration 50 μg/ml of fraction D1, D2, D3, or D4. a, Staphylococcus aureus ATCC 25923;
b, Salmonella typhi ATCC 11778; c, Escherichia coli O157:H7; d, Vibrio cholerae non01; e, Pseudomonas aeruginosa ATCC 27853; f, Streptococcus
epidermidis ATCC 12228; g, Staphylococcus epidermidis clinical isolate; h, Pseudomonas aeruginosa clinical isolate 1; i, Salmonella typhi clinical isolate
1; j, Vibrio cholerae clinical isolate 1; PC, with streptomycin 3 μg/ml in the final concentration; NC, without any of streptomycin and plasma
fractions.
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form pores in the membranes [15].
However, there was no report about the cytotoxicity of
the compound administered to cells of a macrophage-like
cell, RAW 264.7. The present data is the first report. The
MTT assay, to assess the cytotoxicity of the Siamese
crocodile plasma administered to cells of macrophage
RAW 264.7, is an assay of metabolic competence based
on assessment of mitochondrial performance by colori-
metrical measuring of the conversion of yellow tetrazo-
lium bromide (MTT) to the purple formazan derivative
by mitochondrial succinate dehydrogenase in viable cells
[25]. In the present study, the wells incubated with the
crocodile plasma showed light yellow color, whereas the
wells incubated as negative controls showed deep purple.
From the MTT assay mentioned above, the Siamese
crocodile plasma was not cytotoxic to the cells.Conclusions
In summary, the crude and purified plasma from
Crocodylus siamensis showed significantly antibacterial
activity against pathogenic bacteria and reference strains
by damage cell membrane of target bacterial. From the
MTT assay, the Siamese crocodile plasma was not cyto-
toxic to the cells. On the basis of the results obtained
above, the plasma extracted from Crocodylus siamensis
was known to have a significant use as a clinical anti-
microbial agent. So the subsequent studies are required
to focus on the purification and characterization of the
agent responsible for the antimicrobial activities includ-
ing the anti-inflammatory activity.
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